Family Nurse Practitioner Exam

What condition is Terazosin (Hytrin), an alpha blocker, primarily used to treat?

1. Chronic prostatitis and atrial fibrillation

2. Urinary tract infections and arrhythmias

3. Benign prostatic hypertrophy and hypertension

4. Benign prostatic hypertrophy and chronic prostatitis

The correct answer is: Benign prostatic hypertrophy and hypertension

Terazosin (Hytrin) is primarily used to treat benign prostatic hypertrophy (BPH) and hypertension due to its mechanism of action as an alpha-1 adrenergic antagonist. In men with BPH, terazosin helps to relax the smooth muscles in the prostate and bladder neck, leading to improved urinary flow and reduced symptoms associated with an enlarged prostate. This is particularly beneficial in alleviating symptoms such as difficulty urinating, weak urine stream, and frequent urination. In addition to its role in managing BPH, terazosin is also effective in treating hypertension. By blocking alpha-1 adrenergic receptors, terazosin causes vasodilation, which leads to a decrease in blood pressure. This dual action makes terazosin a valuable medication for patients who may have both conditions. While chronic prostatitis and atrial fibrillation, urinary tract infections and arrhythmias, or chronic prostatitis are all medical concerns, they do not align with the primary indications for terazosin. Understanding the specific indications of medications like terazosin is crucial for effective patient management in primary care settings.